Protein Binding Assays Market by Technology (Equillibrium Dialysis, Ultrafiltration, Ultracentrifugation, Gel Filtration Chromatography), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organization) - Global Forecast to 2023
“The global protein binding assay market is projected to grow at a CAGR of 10.7%.”
The protein binding assay market is projected to reach USD 425.7 million in 2023 from USD 256.1 million in 2018, at CAGR of 10.7% during the forecast period. Factors such as the growing number of drug discovery activities, increasing pressure to reduce drug discovery and development costs, and the increase in pharmaceutical R&D expenditure are driving market growth. Issues concerning existing technologies and the development of in silico-based prediction models are expected to challenge market growth to a certain extent.
“Pharmaceutical and biotechnology companies are expected to account for the largest share of the protein binding assay market in 2018.”
By end user, the protein binding assay market is divided into pharmaceutical & biotechnology companies, CROs, and other end users. In 2018, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the protein binding assay market. Protein binding assays play a pivotal role in ADME procedures, owing to which they are widely used by pharmaceutical & biotechnology companies to evaluate drug candidates based on their binding capacity with proteins.
“The equilibrium dialysis segment is expected to dominate the market in 2018.”
On the basis of technology, the protein binding assay market is segmented into equilibrium dialysis, ultrafiltration, ultracentrifugation, and other technologies. The equilibrium dialysis segment is expected to account for the largest share of the protein binding assay market. The large share and high growth rate of this segment can be attributed to the advantages associated with the use of equilibrium dialysis, which include physical simplicity, low costs, and high accuracy. The simpler workflow equilibrium dialysis also makes it the preferred choice for protein binding studies.
“North America is expected to account for the largest share of the market in 2018.”
By geography, North America is expected to account for the largest share of the protein binding assay market in 2018, followed by Europe. The well-established pharmaceutical industry, presence of leading pharmaceutical and biotechnology companies, and high R&D investments in North America are the key drivers for this regional market.
Break-up profile of primaries:
RESEARCH COVERAGE:
The protein binding assay market in this report is segmented by technology and end user. The study tracks and analyzes competitive developments such as product launches, collaborations, agreements, partnerships, and acquisitions. It also profiles key players and their core competencies in the protein binding assay market.
Reasons to buy this report:
The report provides insights on the following pointers:
The protein binding assay market is projected to reach USD 425.7 million in 2023 from USD 256.1 million in 2018, at CAGR of 10.7% during the forecast period. Factors such as the growing number of drug discovery activities, increasing pressure to reduce drug discovery and development costs, and the increase in pharmaceutical R&D expenditure are driving market growth. Issues concerning existing technologies and the development of in silico-based prediction models are expected to challenge market growth to a certain extent.
“Pharmaceutical and biotechnology companies are expected to account for the largest share of the protein binding assay market in 2018.”
By end user, the protein binding assay market is divided into pharmaceutical & biotechnology companies, CROs, and other end users. In 2018, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the protein binding assay market. Protein binding assays play a pivotal role in ADME procedures, owing to which they are widely used by pharmaceutical & biotechnology companies to evaluate drug candidates based on their binding capacity with proteins.
“The equilibrium dialysis segment is expected to dominate the market in 2018.”
On the basis of technology, the protein binding assay market is segmented into equilibrium dialysis, ultrafiltration, ultracentrifugation, and other technologies. The equilibrium dialysis segment is expected to account for the largest share of the protein binding assay market. The large share and high growth rate of this segment can be attributed to the advantages associated with the use of equilibrium dialysis, which include physical simplicity, low costs, and high accuracy. The simpler workflow equilibrium dialysis also makes it the preferred choice for protein binding studies.
“North America is expected to account for the largest share of the market in 2018.”
By geography, North America is expected to account for the largest share of the protein binding assay market in 2018, followed by Europe. The well-established pharmaceutical industry, presence of leading pharmaceutical and biotechnology companies, and high R&D investments in North America are the key drivers for this regional market.
Break-up profile of primaries:
- By Company Type- Tier 1-33%, Tier 2-40% and Tier 3-27%
- By Designation- C-level-21%, D-level-36% and Others-43%
- By Region- North America-43%, Europe-31%, Asia Pacific-18%, and RoW-8%
RESEARCH COVERAGE:
The protein binding assay market in this report is segmented by technology and end user. The study tracks and analyzes competitive developments such as product launches, collaborations, agreements, partnerships, and acquisitions. It also profiles key players and their core competencies in the protein binding assay market.
Reasons to buy this report:
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the portfolios offered by the top players in the protein binding assay market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global protein binding assay market
- Market Development: Comprehensive information about lucrative emerging markets—the report analyzes markets for protein binding assay products across regions
- Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the market
- Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global protein binding assay market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS COVERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PROTEIN BINDING ASSAY: MARKET OVERVIEW
4.2 EUROPE: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY & COUNTRY (2018)
4.3 PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY (2018 VS. 2023)
4.4 GEOGRAPHIC SNAPSHOT OF THE PROTEIN BINDING ASSAY MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rise in drug discovery activities
5.2.1.2 Growing pressure to reduce drug discovery and development costs
5.2.1.3 Increase in pharmaceutical R&D expenditure
5.2.2 RESTRAINTS
5.2.2.1 Issues with existing technologies
5.2.3 OPPORTUNITIES
5.2.3.1 Growing CRO Industry
5.2.4 CHALLENGES
5.2.4.1 Development of in silico-based prediction models
6 PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
6.2 EQUILIBRIUM DIALYSIS
6.3 ULTRAFILTRATION
6.4 ULTRACENTRIFUGATION
6.5 OTHER TECHNOLOGIES
7 PROTEIN BINDING ASSAY MARKET, BY END USER
7.1 INTRODUCTION
7.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
7.3 CONTRACT RESEARCH ORGANIZATIONS
7.4 OTHER END USERS
8 PROTEIN BINDING ASSAY MARKET, BY REGION
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 US
8.2.2 CANADA
8.3 EUROPE
8.3.1 GERMANY
8.3.2 UK
8.3.3 FRANCE
8.3.4 REST OF EUROPE
8.4 ASIA PACIFIC
8.4.1 CHINA
8.4.2 INDIA
8.4.3 REST OF ASIA PACIFIC
8.5 REST OF THE WORLD
9 COMPETITIVE LANDSCAPE
9.1 MARKET OVERVIEW
9.2 MARKET RANKING ANALYSIS, 2018
9.3 COMPETITIVE SITUATION AND TRENDS
9.3.1 COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS
9.3.2 ACQUISITIONS
10 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
10.1 MERCK
10.2 THERMO FISHER SCIENTIFIC
10.3 GE HEALTHCARE
10.4 SOVICELL GMBH
10.5 ABSORPTION SYSTEMS
10.6 HTDIALYSIS
10.7 EUROFINS SCIENTIFIC
10.8 ADMECELL
10.9 3B PHARMACEUTICALS
10.10 BIOTIUM
10.11 DANAHER CORPORATION
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
11 APPENDIX
11.1 INSIGHTS OF INDUSTRY EXPERTS
11.2 DISCUSSION GUIDE
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.4 AVAILABLE CUSTOMIZATIONS
11.5 RELATED REPORTS
11.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS COVERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PROTEIN BINDING ASSAY: MARKET OVERVIEW
4.2 EUROPE: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY & COUNTRY (2018)
4.3 PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY (2018 VS. 2023)
4.4 GEOGRAPHIC SNAPSHOT OF THE PROTEIN BINDING ASSAY MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rise in drug discovery activities
5.2.1.2 Growing pressure to reduce drug discovery and development costs
5.2.1.3 Increase in pharmaceutical R&D expenditure
5.2.2 RESTRAINTS
5.2.2.1 Issues with existing technologies
5.2.3 OPPORTUNITIES
5.2.3.1 Growing CRO Industry
5.2.4 CHALLENGES
5.2.4.1 Development of in silico-based prediction models
6 PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
6.2 EQUILIBRIUM DIALYSIS
6.3 ULTRAFILTRATION
6.4 ULTRACENTRIFUGATION
6.5 OTHER TECHNOLOGIES
7 PROTEIN BINDING ASSAY MARKET, BY END USER
7.1 INTRODUCTION
7.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
7.3 CONTRACT RESEARCH ORGANIZATIONS
7.4 OTHER END USERS
8 PROTEIN BINDING ASSAY MARKET, BY REGION
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 US
8.2.2 CANADA
8.3 EUROPE
8.3.1 GERMANY
8.3.2 UK
8.3.3 FRANCE
8.3.4 REST OF EUROPE
8.4 ASIA PACIFIC
8.4.1 CHINA
8.4.2 INDIA
8.4.3 REST OF ASIA PACIFIC
8.5 REST OF THE WORLD
9 COMPETITIVE LANDSCAPE
9.1 MARKET OVERVIEW
9.2 MARKET RANKING ANALYSIS, 2018
9.3 COMPETITIVE SITUATION AND TRENDS
9.3.1 COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS
9.3.2 ACQUISITIONS
10 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
10.1 MERCK
10.2 THERMO FISHER SCIENTIFIC
10.3 GE HEALTHCARE
10.4 SOVICELL GMBH
10.5 ABSORPTION SYSTEMS
10.6 HTDIALYSIS
10.7 EUROFINS SCIENTIFIC
10.8 ADMECELL
10.9 3B PHARMACEUTICALS
10.10 BIOTIUM
10.11 DANAHER CORPORATION
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
11 APPENDIX
11.1 INSIGHTS OF INDUSTRY EXPERTS
11.2 DISCUSSION GUIDE
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.4 AVAILABLE CUSTOMIZATIONS
11.5 RELATED REPORTS
11.6 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 2 PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, PROTEIN BINDING VIALS/TUBES (UNITS)
TABLE 3 PROTEIN BINDING ASSAY MARKET FOR EQUILIBRIUM DIALYSIS, BY REGION, 2016–2023 (USD MILLION)
TABLE 4 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR EQUILIBRIUM DIALYSIS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 5 EUROPE: PROTEIN BINDING ASSAY MARKET FOR EQUILIBRIUM DIALYSIS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 6 APAC: PROTEIN BINDING ASSAY MARKET FOR EQUILIBRIUM DIALYSIS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 7 PROTEIN BINDING ASSAY MARKET FOR ULTRAFILTRATION, BY REGION, 2016–2023 (USD MILLION)
TABLE 8 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR ULTRAFILTRATION, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 9 EUROPE: PROTEIN BINDING ASSAY MARKET FOR ULTRAFILTRATION, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 10 APAC: PROTEIN BINDING ASSAY MARKET FOR ULTRAFILTRATION, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 11 PROTEIN BINDING ASSAY MARKET FOR ULTRACENTRIFUGATION, BY REGION, 2016–2023 (USD MILLION)
TABLE 12 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR ULTRACENTRIFUGATION, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 13 EUROPE: PROTEIN BINDING ASSAY MARKET FOR ULTRACENTRIFUGATION, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 14 APAC: PROTEIN BINDING ASSAY MARKET FOR ULTRACENTRIFUGATION, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 15 PROTEIN BINDING ASSAY MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2016–2023 (USD MILLION)
TABLE 16 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 17 EUROPE: PROTEIN BINDING ASSAY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 18 APAC: PROTEIN BINDING ASSAY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 19 PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 20 PROTEIN BINDING ASSAY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2023 (USD MILLION)
TABLE 21 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 22 EUROPE: PROTEIN BINDING ASSAY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 23 APAC: PROTEIN BINDING ASSAY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 24 PROTEIN BINDING ASSAY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2016–2023 (USD MILLION)
TABLE 25 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 26 EUROPE: PROTEIN BINDING ASSAY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 27 APAC: PROTEIN BINDING ASSAY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 28 PROTEIN BINDING ASSAY MARKET FOR OTHER END USERS, BY REGION, 2016–2023 (USD MILLION)
TABLE 29 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 30 EUROPE: PROTEIN BINDING ASSAY MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 31 APAC: PROTEIN BINDING ASSAY MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 32 PROTEIN BINDING ASSAY MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 33 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 34 EUROPE: PROTEIN BINDING ASSAY MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 35 APAC: PROTEIN BINDING ASSAY MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 36 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 37 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 38 US: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 39 US: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 40 CANADA: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 41 CANADA: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 42 EUROPE: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 43 EUROPE: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 44 GERMANY: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 45 GERMANY: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 46 UK: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 47 UK: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 48 FRANCE: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 49 FRANCE: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 50 ROE: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 51 ROE: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 52 APAC: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 53 APAC: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 54 CHINA: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 55 CHINA: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 56 INDIA: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 57 INDIA: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 58 ROAPAC: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 59 ROAPAC: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 60 ROW: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 61 ROW: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 62 COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS, 2015–2018
TABLE 63 ACQUISITIONS, 2015-2018
TABLE 1 PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 2 PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, PROTEIN BINDING VIALS/TUBES (UNITS)
TABLE 3 PROTEIN BINDING ASSAY MARKET FOR EQUILIBRIUM DIALYSIS, BY REGION, 2016–2023 (USD MILLION)
TABLE 4 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR EQUILIBRIUM DIALYSIS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 5 EUROPE: PROTEIN BINDING ASSAY MARKET FOR EQUILIBRIUM DIALYSIS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 6 APAC: PROTEIN BINDING ASSAY MARKET FOR EQUILIBRIUM DIALYSIS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 7 PROTEIN BINDING ASSAY MARKET FOR ULTRAFILTRATION, BY REGION, 2016–2023 (USD MILLION)
TABLE 8 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR ULTRAFILTRATION, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 9 EUROPE: PROTEIN BINDING ASSAY MARKET FOR ULTRAFILTRATION, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 10 APAC: PROTEIN BINDING ASSAY MARKET FOR ULTRAFILTRATION, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 11 PROTEIN BINDING ASSAY MARKET FOR ULTRACENTRIFUGATION, BY REGION, 2016–2023 (USD MILLION)
TABLE 12 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR ULTRACENTRIFUGATION, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 13 EUROPE: PROTEIN BINDING ASSAY MARKET FOR ULTRACENTRIFUGATION, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 14 APAC: PROTEIN BINDING ASSAY MARKET FOR ULTRACENTRIFUGATION, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 15 PROTEIN BINDING ASSAY MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2016–2023 (USD MILLION)
TABLE 16 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 17 EUROPE: PROTEIN BINDING ASSAY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 18 APAC: PROTEIN BINDING ASSAY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 19 PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 20 PROTEIN BINDING ASSAY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2023 (USD MILLION)
TABLE 21 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 22 EUROPE: PROTEIN BINDING ASSAY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 23 APAC: PROTEIN BINDING ASSAY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 24 PROTEIN BINDING ASSAY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2016–2023 (USD MILLION)
TABLE 25 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 26 EUROPE: PROTEIN BINDING ASSAY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 27 APAC: PROTEIN BINDING ASSAY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 28 PROTEIN BINDING ASSAY MARKET FOR OTHER END USERS, BY REGION, 2016–2023 (USD MILLION)
TABLE 29 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 30 EUROPE: PROTEIN BINDING ASSAY MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 31 APAC: PROTEIN BINDING ASSAY MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 32 PROTEIN BINDING ASSAY MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 33 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 34 EUROPE: PROTEIN BINDING ASSAY MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 35 APAC: PROTEIN BINDING ASSAY MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 36 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 37 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 38 US: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 39 US: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 40 CANADA: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 41 CANADA: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 42 EUROPE: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 43 EUROPE: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 44 GERMANY: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 45 GERMANY: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 46 UK: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 47 UK: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 48 FRANCE: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 49 FRANCE: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 50 ROE: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 51 ROE: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 52 APAC: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 53 APAC: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 54 CHINA: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 55 CHINA: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 56 INDIA: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 57 INDIA: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 58 ROAPAC: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 59 ROAPAC: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 60 ROW: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
TABLE 61 ROW: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 62 COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS, 2015–2018
TABLE 63 ACQUISITIONS, 2015-2018
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 BOTTOM-UP APPROACH
FIGURE 4 TOP-DOWN APPROACH
FIGURE 5 DATA TRIANGULATION METHODOLOGY
FIGURE 6 EQUILIBRIUM DIALYSIS TOP REGISTER THE HIGHEST GROWTH IN THE MARKET DURING THE FORECAST PERIOD
FIGURE 7 PHARMACEUTICAL & BIOTECHNOLOGY TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
FIGURE 8 GEOGRAPHIC SNAPSHOT OF PROTEIN BINDING ASSAY MARKET
FIGURE 9 INCREASING DRUG DISCOVERY ACTIVITIES—THE PRIMARY GROWTH DRIVER OF THE PROTEIN BINDING ASSAY MARKET
FIGURE 10 EQUILIBRIUM DIALYSIS TO CONTINUE TO DOMINATE THE PROTEIN BINDING ASSAY MARKET IN THE FORECAST PERIOD
FIGURE 11 APAC TO BE THE FASTEST-GROWING MARKET FROM 2018 TO 2023
FIGURE 12 PROTEIN BINDING ASSAY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 13 GLOBAL PHARMACEUTICAL R&D SPENDING (2010–2024)
FIGURE 14 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET SNAPSHOT
FIGURE 15 ASIA PACIFIC: PROTEIN BINDING ASSAY MARKET SNAPSHOT
FIGURE 16 RANK OF COMPANIES IN THE PROTEIN BINDING ASSAY MARKET, 2018
FIGURE 17 MERCK: COMPANY SNAPSHOT (2017)
FIGURE 18 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017)
FIGURE 19 GE HEALTHCARE: COMPANY SNAPSHOT (2017)
FIGURE 20 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2017)
FIGURE 21 DANAHER CORPORATION: COMPANY SNAPSHOT (2017)
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 BOTTOM-UP APPROACH
FIGURE 4 TOP-DOWN APPROACH
FIGURE 5 DATA TRIANGULATION METHODOLOGY
FIGURE 6 EQUILIBRIUM DIALYSIS TOP REGISTER THE HIGHEST GROWTH IN THE MARKET DURING THE FORECAST PERIOD
FIGURE 7 PHARMACEUTICAL & BIOTECHNOLOGY TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
FIGURE 8 GEOGRAPHIC SNAPSHOT OF PROTEIN BINDING ASSAY MARKET
FIGURE 9 INCREASING DRUG DISCOVERY ACTIVITIES—THE PRIMARY GROWTH DRIVER OF THE PROTEIN BINDING ASSAY MARKET
FIGURE 10 EQUILIBRIUM DIALYSIS TO CONTINUE TO DOMINATE THE PROTEIN BINDING ASSAY MARKET IN THE FORECAST PERIOD
FIGURE 11 APAC TO BE THE FASTEST-GROWING MARKET FROM 2018 TO 2023
FIGURE 12 PROTEIN BINDING ASSAY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 13 GLOBAL PHARMACEUTICAL R&D SPENDING (2010–2024)
FIGURE 14 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET SNAPSHOT
FIGURE 15 ASIA PACIFIC: PROTEIN BINDING ASSAY MARKET SNAPSHOT
FIGURE 16 RANK OF COMPANIES IN THE PROTEIN BINDING ASSAY MARKET, 2018
FIGURE 17 MERCK: COMPANY SNAPSHOT (2017)
FIGURE 18 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017)
FIGURE 19 GE HEALTHCARE: COMPANY SNAPSHOT (2017)
FIGURE 20 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2017)
FIGURE 21 DANAHER CORPORATION: COMPANY SNAPSHOT (2017)
